Log in

OTCMKTS:CHGCYChugai Pharmaceutical Stock Price, Forecast & News

+0.23 (+0.10 %)
(As of 04/5/2020 03:50 AM ET)
Today's Range
Now: $226.20
50-Day Range
MA: $211.96
52-Week Range
Now: $226.20
Volume4,001 shs
Average Volume5,268 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, marketing, and distribution of prescription medicines in Japan and internationally. The company's products for oncology primarily include Avastin, Herceptin, Rituxan, Alecensa, Perjeta, Xeloda, Tarceva, Kadcyla, Zelboraf, Neutrogin, Tecentriq, and Gazyva; bone and joint diseases/autoimmune diseases comprise Actemra, Edirol, Suvenyl, and Bonviva; renal diseases consist of Mircera and Oxarol; and transplant, immunology, infectious, and other diseases comprise Tamiflu, CellCept, Copegus, and Hemlibra. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group and Genentech; co-development agreements with Taisho Pharmaceutical Co., Ltd. and Nippon Shinyaku Co., Ltd.; and collaborative research agreement with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers—General
Phone81 3 3281 6611



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive CHGCY News and Ratings via Email

Sign-up to receive the latest news and ratings for CHGCY and its competitors with MarketBeat's FREE daily newsletter.

Chugai Pharmaceutical (OTCMKTS:CHGCY) Frequently Asked Questions

How has Chugai Pharmaceutical's stock been impacted by COVID-19 (Coronavirus)?

Chugai Pharmaceutical's stock was trading at $206.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CHGCY stock has increased by 9.6% and is now trading at $226.20. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Chugai Pharmaceutical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chugai Pharmaceutical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Chugai Pharmaceutical.

Has Chugai Pharmaceutical been receiving favorable news coverage?

News stories about CHGCY stock have trended very negative recently, according to InfoTrie. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Chugai Pharmaceutical earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutChugai Pharmaceutical.

Who are some of Chugai Pharmaceutical's key competitors?

Who are Chugai Pharmaceutical's key executives?

Chugai Pharmaceutical's management team includes the following people:
  • Mr. Osamu Nagayama, Chairman (Age 72)
  • Mr. Tatsuro Kosaka, Pres, CEO & Representative Director (Age 66)
  • Mr. Motoo Ueno, Deputy Chairman
  • Mr. Toshiaki Itagaki, EVP, CFO and GM of Fin. Supervisory Division, Fin. & Accounting Dept.
  • Mr. Junichi Ebihara, Sr. VP & GM of Legal Department

What is Chugai Pharmaceutical's stock symbol?

Chugai Pharmaceutical trades on the OTCMKTS under the ticker symbol "CHGCY."

How do I buy shares of Chugai Pharmaceutical?

Shares of CHGCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chugai Pharmaceutical's stock price today?

One share of CHGCY stock can currently be purchased for approximately $226.20.

What is Chugai Pharmaceutical's official website?

The official website for Chugai Pharmaceutical is http://www.chugai-pharm.co.jp/.

How can I contact Chugai Pharmaceutical?

The company can be reached via phone at 81 3 3281 6611.

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel